Author Archives: Cindy Affandi
BIOTECH
STALICLA signs exclusive in-licensing agreement for late-stage clinical neuropsychiatric and neurodevelopmental disorder treatment
STALICLA signs exclusive in-licensing agreement for late-stage clinical neuropsychiatric and neurodevelopmental disorder treatment The transaction with Novartis reinforces STALICLA’s position as the leading developer of precision...
Read more
DIGITAL CLINICAL SOLUTION
RegASK announces US$10m Series A Funding Round led by Monograph Capital to accelerate its growth
SINGAPORE, Dec. 15, 2022 /PRNewswire/ — RegASK, a global RegTech SaaS company, today announced it has raised a $10m Series A...
Read more
BIOTECH
AUM Biosciences, a Global Biotechnology Company Developing Precision Oncology Therapeutics, Announces Plans to Become a Public Company via Merger with Mountain Crest Acquisition Corp. V
The transaction reflects a pre-money equity value of $400 million for AUM Biosciences Transaction is...
Read more
BIOTECH
Stalicla SA and Evgen Pharma plc ink $160.5m licensing deal for SFX-01
Precision neuroscience company Stalicla SA has licensed SFX-01 from Evgen Pharma plc in neurodevelopmental disorders...
Read more
DIGITAL CLINICAL SOLUTION
ObvioHealth Introduces ObvioGo™, a Next-Generation DCT Platform and Mobile Application Delivering Stronger Evidence
NEW YORK – September 14, 2022 – ObvioHealth, a pioneering virtual research organization (VRO), announces...
Read more